glp-1 training for providers Patients are asking about GLP-1s by name. Are you fully equipped to answer? Demand medical weight loss is exploding, but most still have zero formal in anti-obesity medications, microdosing GLP-1 and Strength Training: Protect

GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists: strengthened warnings on acute pancreatitis including necrotising and fatal cases

& Xu, E

Understanding this nuanced relationship helps patients and clinicians make informed decisions about GLP-1 therapy while protecting vision through appropriate monitoring and individualized treatment approaches

While we always personalize treatment, heres a general starting point we use when creating a plan: Dosage: 250 to 500 mcg per day Method: Subcutaneous injection near the affected joint Cycle: 4 weeks on, followed by 2 to 4 weeks off Duration: Usually 1 to 3 cycles, depending on severity Injectable BPC-157 is preferred for arthritis

Culasso, L

The follicles didn't just survive in the lab